Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-05-13 @ 11:28 PM
Study NCT ID:
NCT04523493
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-09
First Post:
2020-07-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Study of Toripalimab（JS001） Combined With Lenvatinib for Advanced HCC
Sponsor:
Shanghai Junshi Bioscience Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Hepatocellular Carcinoma (HCC) | View |
Keywords: